ipo of stent maker xtent rises in debut new york yesterdays lone new stock offering for medical device company xtent inc rose the menlo park calif company closed at &# above its initial public offering price of &# in p m nasdaq stock market composite trading xtent sold million shares at the low end of its expected &# to &# price range which was set by underwriters piper jaffray cos cowen &amp co lazard capital markets and rbc capital markets xtent was the fifth company to go public this week as the ipo market slips into gear after the holiday break biopharmaceutical company molecular insight pharmaceuticals inc is expected to make its public debut today on nasdaq a development stage medical device company xtent is working toward the commercialization of its drug eluting stent systems for the treatment of coronary artery disease as of sept it had an accumulated deficit of &# million 
